Cyclic single channel neuromuscular stimulation
DeviceCyclic single channel neuromuscular stimulation is used to trigger repetitive muscular contractions
NCT Number: NCT07098572
This study will compare two treatments that may help participants recover after having suffered from stroke. Persons who experience weakness or paralysis of their arms/hands will be randomly placed in one of two groups. Each receives treatment five times a week for three weeks. One group will be treated with electrostimulation following a cyclic pattern (control treatment), the other group will be treated with electrostimulation triggered by nerve signals (i.e. stimulation starts when they deliberately try to move their arm (investigational treatment). Before and after the three weeks and additionally 12 weeks later, the ability to move the arm and hand will be documented with standardized tests.
Interested in participating?
Request Info18 year–99 year
All sexes
Interventional
Not applicable
KABEG Gailtal-Klinik LKH Hermagor, Hermagor, Carinthia, Austria
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Cyclic single channel neuromuscular stimulation is used to trigger repetitive muscular contractions
EMG-MES provides biofeedback by using electromyographic signals to trigger muscular contractions
Other names: EMG-MES
Time frame: pre-intervention to 3 weeks
Scores between 0 and 100, higher meaning a better outcome
Time frame: pre-intervention to 3 weeks
Scores between 0 and 100, higher meaning a better outcome
Time frame: pre-intervention to 3 weeks
Scores between 0 and 100, higher meaning a better outcome
Time frame: pre-intervention to 3 weeks
Scores between 0 and 100, higher meaning a better outcome
Time frame: pre-intervention to 3 weeks
Scores between 0 and 100, higher meaning a better outcome
Time frame: pre-intervention to 3 weeks
Scores between 0 and 100, higher meaning a better outcome
Time frame: pre-intervention to 3 weeks
Scores between 0 and 57, higher meaning a better outcome
Time frame: through study completion, an average of 15 weeks
Assessment of device related adverse events
Contact information is provided by the study sponsor or research team.
MED-EL Elektromedizinische Geräte GesmbH
Industry
Efficacy of EMG-triggered Four-Channel Functional Electrical Stimulation vs. Cyclic One-Channel Electrical Stimulation on Moderate Arm/Hand Paresis in Subacute Stroke Patients. A Randomized Controlled Single Blinded Multicenter Study
Acronym: MKES2
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06286800
Brain Diseases, Cardiovascular Diseases
Houston, Texas, United States
View Trial DetailsNCT07053917
Brain Diseases, Brain Infarction
Baltimore, Maryland, United States
View Trial DetailsNCT06722677
Brain Diseases, Cardiovascular Diseases
Hefei, Anhui, China
View Trial DetailsNCT04534556
Brain Diseases, Cardiovascular Diseases
Dallas, Texas, United States
View Trial Details